DALLAS BROWN: Open Payments
NPI 1538822010 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 24 payments from 6 companies in 2025. Trend: 2023 $175 · 2024 $439 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 9 | $225 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $147 |
| Astellas Pharma US Inc | 5 | $107 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
Products named: ZURZUVAE, Veozah, GARDASIL 9, SLYND, JOURNAVX.
Industry payments across TX — which companies pay providers there.
